- Home
- TARA vs RVSB Comparison
TARA vs RVSB Comparison
Compare TARA & RVSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- RVSB
- Stock Information
- Founded
- TARA N/A
- RVSB 1923
- Country
- TARA United States
- RVSB United States
- Employees
- TARA N/A
- RVSB 238
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- RVSB Savings Institutions
- Sector
- TARA Health Care
- RVSB Finance
- Exchange
- TARA Nasdaq
- RVSB Nasdaq
- Market Cap
- TARA 126.5M
- RVSB 115.6M
- IPO Year
- TARA N/A
- RVSB 1993
- Fundamental
- Price
- TARA $2.80
- RVSB $5.68
- Analyst Decision
- TARA Strong Buy
- RVSB Buy
- Analyst Count
- TARA 7
- RVSB 1
- Target Price
- TARA $20.67
- RVSB $7.00
- AVG Volume (30 Days)
- TARA 478.9K
- RVSB 241.9K
- Earning Date
- TARA 08-05-2025
- RVSB 07-24-2025
- Dividend Yield
- TARA N/A
- RVSB 1.45%
- EPS Growth
- TARA N/A
- RVSB 27.97
- EPS
- TARA N/A
- RVSB 0.23
- Revenue
- TARA N/A
- RVSB $50,239,000.00
- Revenue This Year
- TARA N/A
- RVSB $12.68
- Revenue Next Year
- TARA N/A
- RVSB $11.53
- P/E Ratio
- TARA N/A
- RVSB $23.91
- Revenue Growth
- TARA N/A
- RVSB 3.95
- 52 Week Low
- TARA $1.60
- RVSB $3.30
- 52 Week High
- TARA $10.48
- RVSB $6.59
- Technical
- Relative Strength Index (RSI)
- TARA 39.61
- RVSB 57.17
- Support Level
- TARA $3.12
- RVSB $5.47
- Resistance Level
- TARA $3.10
- RVSB $5.65
- Average True Range (ATR)
- TARA 0.19
- RVSB 0.17
- MACD
- TARA -0.01
- RVSB 0.04
- Stochastic Oscillator
- TARA 1.39
- RVSB 84.11
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.